Co-Authors
This is a "connection" page, showing publications co-authored by EKERE ESSIEN and MICHAEL JOHNSON.
Connection Strength
0.506
-
Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study. Harm Reduct J. 2024 Dec 20; 21(1):220.
Score: 0.059
-
The role of implementing instructional design principles on learner experience with training in current good manufacturing practices (cGMP). Curr Pharm Teach Learn. 2024 Aug; 16(8):102091.
Score: 0.056
-
Trajectories of adherence to ACEI/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas. Patient Educ Couns. 2024 Feb; 119:108073.
Score: 0.055
-
A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Drugs Aging. 2023 04; 40(4):377-390.
Score: 0.052
-
Patient-Reported Barriers to Adherence Among ACEI/ARB Users from a Motivational Interviewing Telephonic Intervention. Patient Prefer Adherence. 2022; 16:2739-2748.
Score: 0.051
-
Group-Based Trajectory Modeling to Identify Patterns of Adherence and Its Predictors Among Older Adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)/Angiotensin Receptor Blockers (ARBs). Patient Prefer Adherence. 2020; 14:1935-1947.
Score: 0.044
-
Patient-reported barriers to statin adherence: Excerpts from a?motivational interviewing intervention in older adults. J Am Pharm Assoc (2003). 2021 Jan-Feb; 61(1):60-67.e1.
Score: 0.044
-
Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence. J Manag Care Spec Pharm. 2019 Oct; 25(10):1053-1062.
Score: 0.041
-
Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults. Am Health Drug Benefits. 2019 Jun-Jul; 12(4):202-211.
Score: 0.040
-
Comparative Effectiveness of Smoking Cessation Medications to Attenuate Weight Gain Following Cessation. Subst Use Misuse. 2016; 51(5):586-97.
Score: 0.032
-
Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers. Subst Use Misuse. 2015; 50(13):1628-37.
Score: 0.031